<DOC>
	<DOCNO>NCT00115427</DOCNO>
	<brief_summary>This randomize study design evaluate efficacy safety IPu-infused liatermin ( 15mg/putamen/day ) compare placebo subject symptomatic , levodopa-response Parkinson 's disease . This study consist 90-day evaluation period follow implantation IPu delivery system 6-month double-blind treatment period .</brief_summary>
	<brief_title>Study Liatermin ( r-metHuGDNF ) Administered Bilateral Intraputaminal ( IPu ) Infusion Subjects With Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosis bilateral , idiopathic Parkinson 's disease</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Bilateral , Idiopathic Parkinson 's Disease</keyword>
</DOC>